Galera Therapeutics (NASDAQ:GRTX) reported quarterly losses of $(0.54) per share. This is a 38.64 percent increase over losses of $(0.88) per share from the same period last year.
Cheniere And BASF Sign Long-Term LNG Sale And Purchase Agreement; BASF Has Agreed To Purchase Up To ~0.8 Million Tonnes Per Annum Of LNG From Cheniere Marketing
Long-term SPA Expected to Support Sabine Pass Expansion Project
Cheniere Energy, Inc. ("Cheniere" or the "Company") (NYSE:LNG) announced today that Cheniere's subsidiary, Cheniere Marketing, LLC
